DD202034A5 - Verfahren zur herstellung von 4-pregnenderivaten - Google Patents

Verfahren zur herstellung von 4-pregnenderivaten Download PDF

Info

Publication number
DD202034A5
DD202034A5 DD81235333A DD23533381A DD202034A5 DD 202034 A5 DD202034 A5 DD 202034A5 DD 81235333 A DD81235333 A DD 81235333A DD 23533381 A DD23533381 A DD 23533381A DD 202034 A5 DD202034 A5 DD 202034A5
Authority
DD
German Democratic Republic
Prior art keywords
epimer
hydroxyl group
acid
esterified
epimers
Prior art date
Application number
DD81235333A
Other languages
German (de)
English (en)
Inventor
Bror A Thalen
Ralph L Brattsand
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of DD202034A5 publication Critical patent/DD202034A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Treating Waste Gases (AREA)
  • Peptides Or Proteins (AREA)
DD81235333A 1980-12-04 1981-12-02 Verfahren zur herstellung von 4-pregnenderivaten DD202034A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8008524A SE8008524L (sv) 1980-12-04 1980-12-04 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand

Publications (1)

Publication Number Publication Date
DD202034A5 true DD202034A5 (de) 1983-08-24

Family

ID=20342392

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81235333A DD202034A5 (de) 1980-12-04 1981-12-02 Verfahren zur herstellung von 4-pregnenderivaten

Country Status (26)

Country Link
US (1) US4404200A (fi)
EP (1) EP0054010B1 (fi)
JP (1) JPS57122100A (fi)
KR (1) KR870001904B1 (fi)
AT (1) ATE11920T1 (fi)
AU (1) AU546379B2 (fi)
CA (1) CA1183835A (fi)
CS (1) CS229923B2 (fi)
CY (1) CY1413A (fi)
DD (1) DD202034A5 (fi)
DE (1) DE3169108D1 (fi)
DK (1) DK163003C (fi)
ES (1) ES8306164A1 (fi)
FI (1) FI70582C (fi)
GR (1) GR76919B (fi)
HK (1) HK11688A (fi)
HU (1) HU183717B (fi)
IE (1) IE51923B1 (fi)
MY (1) MY8600139A (fi)
NO (1) NO158508C (fi)
NZ (1) NZ199141A (fi)
PH (1) PH17826A (fi)
PT (1) PT74078B (fi)
SE (1) SE8008524L (fi)
SU (1) SU1156600A3 (fi)
ZA (1) ZA817772B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5866866A (ja) * 1981-10-16 1983-04-21 Advantest Corp 波形等の表示装置
JPS5866867A (ja) * 1981-10-16 1983-04-21 Advantest Corp 波形等の表示装置
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
SE8903219D0 (sv) * 1989-10-02 1989-10-02 Astra Ab Process for the manufacture of budesonide
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
AU672669B2 (en) * 1992-12-24 1996-10-10 Rhone-Poulenc Rorer Limited New steroids
WO1994015947A1 (en) * 1993-01-08 1994-07-21 Astra Aktiebolag Novel colon- or ileum-specific steroid derivatives
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11011063B2 (en) * 2018-11-16 2021-05-18 Toyota Motor North America, Inc. Distributed data collection and processing among vehicle convoy members
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB909126A (en) * 1958-03-11 1962-10-24 American Cyanamid Co 16ª--17ª--alkylidenedioxy steroids and process for preparation
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3549498A (en) * 1968-04-02 1970-12-22 Squibb & Sons Inc 11alpha-substituted steroids and process
CH513843A (fr) * 1969-04-23 1971-10-15 Lark Spa Procédé d'oxhydrilation microbiologique en position 11B
SE378110B (fi) * 1972-05-19 1975-08-18 Bofors Ab
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
SE378109B (fi) * 1972-05-19 1975-08-18 Bofors Ab
ES487089A0 (es) 1979-12-19 1980-12-01 Espanola Esteroide Procedimiento de obtencion de esteroides 11 sustituidos

Also Published As

Publication number Publication date
JPS57122100A (en) 1982-07-29
EP0054010A1 (en) 1982-06-16
HU183717B (en) 1984-05-28
HK11688A (en) 1988-02-16
SU1156600A3 (ru) 1985-05-15
ATE11920T1 (de) 1985-03-15
NO158508B (no) 1988-06-13
SE8008524L (sv) 1982-06-05
EP0054010B1 (en) 1985-02-20
FI70582C (fi) 1986-09-24
CA1183835A (en) 1985-03-12
DK535981A (da) 1982-06-05
JPS6261599B2 (fi) 1987-12-22
US4404200A (en) 1983-09-13
PH17826A (en) 1985-01-07
AU546379B2 (en) 1985-08-29
PT74078B (en) 1983-12-19
KR870001904B1 (ko) 1987-10-21
NO814098L (no) 1982-06-07
FI813807L (fi) 1982-06-05
MY8600139A (en) 1986-12-31
AU7816981A (en) 1982-06-10
DK163003B (da) 1992-01-06
CS229923B2 (en) 1984-07-16
PT74078A (en) 1982-01-01
GR76919B (fi) 1984-09-04
DE3169108D1 (en) 1985-03-28
FI70582B (fi) 1986-06-06
KR830007715A (ko) 1983-11-04
CY1413A (en) 1988-04-22
NO158508C (no) 1988-09-28
DK163003C (da) 1992-06-01
NZ199141A (en) 1984-09-28
ES507670A0 (es) 1983-05-01
ES8306164A1 (es) 1983-05-01
IE51923B1 (en) 1987-04-29
IE812827L (en) 1982-06-04
ZA817772B (en) 1982-08-25

Similar Documents

Publication Publication Date Title
DD202034A5 (de) Verfahren zur herstellung von 4-pregnenderivaten
DE2323216C3 (de) Verfahren zur Auftrennung von Stereoisomerengemischen von Pregna-1,4dien-11 -ol-33-dionen
DE4129535C2 (de) Pregna-1,4-dien-3,20-dion-16-17-acetal-21-ester, Verfahren zur Herstellung, sowie diese enthaltende pharmazeutische Präparate
DE2323215C3 (de) Pregna-l,4-dien-ll-ol-3,20-dione, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE69228870T2 (de) Neue steroide
EP0135476B1 (de) Steroid Carbonsäureester
EP0701565B1 (de) Neue prednisolonderivate
DE1443957B1 (de) 9 alpha-Chlor- bzw. 9 alpha-Fluor-16 beta-methyl-prednisolon-17,21-diester und ein Verfahren zu deren Herstellung
DE2912331A1 (de) Neue 17 beta -thiocarboxylate von 3-oxo-androst-4-en- bzw. -androsta-1,4-dienderivaten, ihre herstellung und diese enthaltende arzneimittel
DE3687239T2 (de) 16,17-acetal-substituierte androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
DE1643033B2 (de) 9 alpha, 11 beta-dichlor-16 alpha- methyl-1,4-pregnadien-17 alpha, 21-diol- 3,20-dion-17-ester verfahren zu ihrer herstellung und sie enthaltende therapeutische zubereitungen
DE2852055C2 (fi)
DE1618993B1 (de) Verfahren zur Herstellung von 3-(2'-Chloräthylthio)-6-formyl-steroiden
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
EP0011121B1 (de) Hydrocortisonester, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2709078C2 (de) Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2819480C2 (fi)
DE2365992A1 (de) 6 alpha-fluor-17,21-dihydroxy-16 beta-methylpregna-4,9(11)-dien-3,20- dion-17,21-diacetat und verfahren zu dessen herstellung
DE1668661C3 (de) 6-Cyansteroide und Verfahren zu deren Herstellung
CH628067A5 (de) Verfahren zur herstellung neuer 21-acetale von steroid-21-aldehyden.
DE2111114C3 (de) Dexamethason -17 - valeriat und Verfahren zu seiner Herstellung
DE1806158C3 (de) 21-Ester von Steroiden, Verfahren zu deren Herstellung sowie diese enthaltende pharmazeutische Zubereitungen
DE1568308C3 (de) 10.09.65 Schweiz 12624-65 Verfahren zur Herstellung von Delta hoch 4,9,11-Trienen der 19-Norandrostanreihe, 17-oxygenierte 3-Oxo-7 alpha-methyl-Delta hoch 4,9,11-19 norandrostatriene und diese enthaltende pharmazeutische Präparate sowie 3-Oxo-7 alpha -methyl-Delta hoch 5 (10), 9 (11) -19-norandrostadiene
AT361644B (de) Verfahren zur herstellung von neuen d-homosteroiden
DE2308731C3 (fi)